Total amount raised
€10.8 Millions
Latest funding date
06/01/2022
Location
Veri has successfully raised €7,500,000 in a Series A funding round, marking a significant milestone in its journey to improve metabolic health through innovative technology. The company was later acquired by Oura, further solidifying its position in the health and wellness industry.
Keep reading to explore the intricacies of Veri's fundraising journey and the investors backing this transformative platform.
What Is Veri?
Veri, founded on February 1, 2020, is a company based in Helsinki, Southern Finland, Finland. It operates in the health and wellness industry, focusing on metabolic health through innovative technology. The company was founded by Anttoni Aniebonam, Frans Lehmusvaara, and Verneri Jaamuru.
With a team of 11-50 employees, Veri offers a personalized metabolic health program that uses Continuous Glucose Monitors (CGMs) to track glucose levels in real-time. The program provides insights and recommendations to help users stabilize their blood sugar levels, achieve health goals, and reach their ideal weight. Veri has positively impacted over 40,000 lives and was recently acquired by Oura.
How Much Funding Has Veri Raised?
- Seed Round
- Amount Raised: $4 million
- Date: June 2021
- Lead Investors: PROFounders
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funding was aimed at scaling up production, beginning shipments to US-based customers, and expanding growth in Europe.
- Series A
- Amount Raised: €7.5 million
- Date: June 2022
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funding was likely aimed at further product development and market expansion.
Total Amount Raised: $11.5 million
Current Valuation: Not publicly disclosed
Key Investors
- PROFounders Capital
- Details: PROFounders Capital is a venture capital firm that invests in early-stage technology companies. They focus on supporting innovative startups with strong growth potential.
- Investment Focus Areas: Technology startups, innovative solutions, early-stage companies.
- Notable Investments: Not publicly disclosed.
- Lifeline Ventures
- Details: Lifeline Ventures is a Finnish venture capital firm that invests in early-stage companies. They are known for backing high-growth sectors, particularly in healthtech and deep tech.
- Investment Focus Areas: Healthtech, deep tech, high-growth sectors.
- Notable Investments: Not publicly disclosed.
- Accel
- Details: Accel is a global venture capital firm that invests in early and growth-stage companies. They have a broad portfolio across various sectors, including consumer, enterprise, and healthcare.
- Investment Focus Areas: Technology companies, consumer, enterprise, healthcare.
- Notable Investments: Not publicly disclosed.
- Johannes Schildt
- Details: Johannes Schildt is the CEO and co-founder of Kry/Livi, a telemedicine company. He is an angel investor with a focus on healthtech and telemedicine.
- Investment Focus Areas: Healthtech, telemedicine.
- Notable Investments: Kry/Livi.
- Kristian Ranta
- Details: Kristian Ranta is the CEO and co-founder of Meru Health, a digital mental health company. He is an angel investor with a focus on healthtech and digital health solutions.
- Investment Focus Areas: Healthtech, digital health solutions.
- Notable Investments: Meru Health.
What's Next for Veri?
Veri stands at the cusp of significant growth opportunities, particularly in the US market, where only 12% of adults are metabolically healthy. The company aims to address this crisis by providing a personalized nutritionist experience through their wearable device. With a waitlist of 50,000 individuals, the demand is evident, and the potential for expansion is vast.
As Veri begins shipments and expands its market presence, future fundraising opportunities are likely to arise. These funds could be used to scale operations, enhance product features, and form strategic partnerships with healthcare providers and wellness platforms. The increasing focus on preventative medicine and personalized health monitoring further bolsters Veri's growth prospects.
However, challenges such as competition from other health tech companies, regulatory hurdles, and ensuring data privacy and security for users remain. Navigating these obstacles will be crucial for Veri as it continues to innovate and expand its reach in the health and wellness industry.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Veri and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
